Caledonia-gr.jpg
Caledonia Mining Corporation Plc Results for the Year ended December 31, 2023; Notice of Management Conference Call; Dividend Declaration
March 28, 2024 03:00 ET | Caledonia Mining Corporation Plc
ST HELIER, Jersey, March 28, 2024 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or the "Company") (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces its operating and...
Logo.png
Healthier Choices Management Corp. Reports Fourth Quarter 2023 Financial Results and Full Year Fiscal 2023 Results
March 27, 2024 17:00 ET | Healthier Choices Management Corp
-Fourth Quarter Sales of $15.9 Million, Up 29%, and Gross Profit of $5.7 Million, up 41%, over Q4 2022 -Full Year Sales of $55.7 Million, Up 90%, and Gross Profit of $20.3 Million Up 99%; over 2022...
Celcuity+Logo.jpg
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 27, 2024 16:01 ET | Celcuity Inc.
Dosed the first patient in a Phase 1b/2 trial evaluating gedatolisib in combination with darolutamide for the treatment of metastatic castration resistant prostate cancer Presented nonclinical data...
SCU_Stacked_CMYK.jpg
Servus begins fiscal year with strong financial performance and growth
March 27, 2024 09:56 ET | Servus Credit Union
Servus Credit Union continued its strong growth trend with assets reaching $20.6 billion, up $1.8 billion (9.8%), compared to the first quarter of 2023.
sunlands logo.jpg
Sunlands Technology Group Announces Unaudited Fourth Quarter and Full Year 2023 Financial Results
March 22, 2024 04:30 ET | Sunlands Technology Group
BEIJING, March 22, 2024 (GLOBE NEWSWIRE) -- Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s online post-secondary and professional education, today announced...
Celcuity+Logo.jpg
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call
March 20, 2024 07:05 ET | Celcuity Inc.
MINNEAPOLIS, March 20, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it...
BioNTech Announces F
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
March 20, 2024 06:15 ET | BioNTech SE
  Advanced oncology pipeline in mid- and late-stage with plans to have ten or more potentially registrational oncology trials running by the end of 2024Aiming for first oncology launch in 2026 and...
BioNTech veröffentli
BioNTech veröffentlicht Ergebnisse für das vierte Quartal und das Geschäftsjahr 2023 sowie Informationen zur Geschäftsentwicklung
March 20, 2024 06:15 ET | BioNTech SE
Onkologie-Pipeline weiterentwickelt mit Kandidaten im mittleren und fortgeschrittenem Entwicklungsstadium; BioNTech plant mit zehn oder mehr laufenden potenziell zulassungsrelevanten Studien bis Ende...
Logo 400x400.jpg
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
March 14, 2024 16:39 ET | CytoSorbents
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
greylogo.png
VitalHub Announces Q4 2023 Conference Call Date
March 14, 2024 07:30 ET | VitalHub Corp.
TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX:VHIBF) is pleased to announce that it will release its financial results for its quarter...